Company intelligence / Profile preview

Dudnyk

Horsham, Pennsylvania, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Dudnyk is not a drug developer and has no therapeutic pipeline; it is a full-service healthcare marketing and advertising agency focused on pharmaceutical, biotech, and medical device brand strategy, with particular depth in rare diseases, orphan drugs, oncology, and breakthrough molecular medicines.[1][2]

Industry: Consulting

Partnerships

Pharmaceutical companies (brand strategy and launch support, especially in rare diseases and oncology)[1][2][5]Biotech companies (commercial and creative strategy services)[1][5]Medical device companies (healthcare advertising and communications)[1][5]

Beyond the preview

Go deeper on Dudnyk.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dudnyk.

Explore the full profile